In accordance with this study, the Global Polymerase Chain Reaction Market value registered in 2019 was close to USD XXX BN and is predicted to outstretch revenue by USD XXX BN in 2019 with a CAGR of X.XX% during the period of 2019-2026.
Polymerase chain reaction amplifies the small segments of RNA and DNA strands into billions of copies and this technique is majorly exploited in genetic engineering, molecular biology, archeology, drug discovery, and clinical diagnostics. The technology is also utilized in forensics to identify criminals and also in child identity. Moreover, PCR is also used in diagnosis of diseases including AIDS, tuberculosis, Lyme diseases, and middle ear infections. Specific technology segments of PCR such as qPCR (real-time PCR) and dPCR (digital PCR) provides real-time process monitoring, automation of workflow, low reagent consumption, and greater reproducibility & precision. Furthermore, polymerase chain reaction is an easy and cost-efficient procedure to replicate the focuses DNA segment.
Personalized medicine which focuses to offer tailor-made therapies to individual patients is gaining immense traction over the last few years. Personalized medicine provides better patient care coupled with high safety margin and also lowers the overall healthcare costs. Increasing demand for personalized medicine created immense opportunities in the field of genetic medicine. To gain a competitive edge in the development of personalized medicine pharmaceutical and biotechnology firms are exploiting genomic medicine and direct to consumer genetic testing. In order to develop these products various R&D activities are being conducted in the field of biotechnology where PCR find its immense applications.
Moreover, PCR is also utilized in molecular diagnosis of genetic and infectious diseases. Genetic tests are crucial in detecting the genetic variations and to predict the response of an individual to certain drugs. To promote personalized medicine, PCR technologies are widely used to attain accurate and precise molecular information about the underlying disease. Hence, increasing attention on personalized medicine and patient centered approach is propelling the growth of the market. However, the advent of alternative technologies such as next generation sequencing coupled with high cost of commercial PCR technologies hampers the market growth. Increase in the funding for R&D activities and the presence of untapped market in emerging economies are anticipated to provide lucrative opportunities for the market in the forecast period.
The report has been created by using crucial tools such as Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis to help businesses around the globe navigate opportunities and challenges in the rapidly evolving marketplace with clarity. These tools also serve the detailed information of each application/product segment in the global market of polymerase chain reaction.
The study offers a decisive view of the global polymerase chain reaction market by segmenting it terms of product, application, and end-user. The report analyzes these subsets with respect to the regional segmentation. This research study will prepare marketers for the evolving needs of their customers.
- Standard PCR Systems
- Digital PCR Systems
- Real-Time PCR Systems
- Reagents & Consumables
- Clinical Diagnostics
- Life Science Research & Industrial Applications
- Academic Institutes
- Clinical Diagnostics Labs & Hospitals
- Pharmaceutical & Biotechnology Industries
This section covers polymerase chain reaction market for the regions North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional segmentation has been done based on the present and future trends in the global polymerase chain reaction market along with the individual application segment across all the prominent region.
Europe Polymerase Chain Reaction Market By Revenue (USD MN)
This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global polymerase chain reaction market are Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation, Siemens Healthcare, and Thermo Fisher Scientific Inc. This section cover profiling of major players in terms of important aspects such as company overview, financial overview, business strategy, and recent developments undertaken during the forecast horizon.
The projections featured in the report have been derived by using primary and secondary research. Secondary research has been carried out by using various sources which include (but not limited to) Corporate Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different trade publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.